Powassan virus encephalitis, Minnesota, USA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

1. Powassan Virus in the United States: An AI-Integrative One Health Scoping Review of Ecological Drivers, Zoonotic Interactions, Symptom Profiles, and Public Health Implications.Infectious disease reports · 2026
   Review
2. Pathogenicity and virulence of Powassan virus.Virulence · 2025
   Review
3. TITAN-RNA: A hybrid-capture sequencing panel detects known and unknownbioRxiv : the preprint server for biology · 2025
   Article
4. Powassan Virus Encephalitis in an Immunocompromised Patient: A Diagnostic Challenge With Case Report and Literature Review.Case reports in infectious diseases · 2025
   Article
5. Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.Viruses · 2024
   Review
6. Powassan Virus Infections: A Systematic Review of Published Cases.Tropical medicine and infectious disease · 2023
   Review
7. Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia.Blood cancer journal · 2022
   Article
8. Emerging tick-borne pathogens of public health importance: a mini-review.Journal of medical microbiology · 2020
   Review
9. Extensive Diversity of RNA Viruses in Australian Ticks.Journal of virology · 2019
   Article
10. Tick-Borne Flaviviruses, with a Focus on Powassan Virus.Clinical microbiology reviews · 2019
    Review
11. Prevalence and distribution of seven human pathogens in host-seeking Ixodes scapularis (Acari: Ixodidae) nymphs in Minnesota, USA.Ticks and tick-borne diseases · 2018
    Article
12. Powassan virus postencephalitic parkinsonism.Neurology. Clinical practice · 2017
    Article
13. Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2017
    Review
14. Development of a Model System for Tick-Borne Flavivirus Persistence in HEK 293T Cells.mBio · 2015
    Article
15. Emerging and reemerging neurologic infections.The Neurohospitalist · 2014
    Article
16. Population-based passive tick surveillance and detection of expanding foci of blacklegged ticks Ixodes scapularis and the Lyme disease agent Borrelia burgdorferi in Ontario, Canada.PloS one · 2014
    Article
17. Potential role of deer tick virus in Powassan encephalitis cases in Lyme disease-endemic areas of New York, U.S.A.Emerging infectious diseases · 2013
    Article
18. Isolation of deer tick virus (Powassan virus, lineage II) from Ixodes scapularis and detection of antibody in vertebrate hosts sampled in the Hudson Valley, New York State.Parasites & vectors · 2013
    Article
19. Powassan virus encephalitis, Minnesota, USA.Emerging infectious diseases · 2013
    Article
20. Powassan virus infection: case series and literature review from a single institution.BMC research notes · 2012
    Review

Corrections and comments

• Commented on by
  Powassan virus encephalitis, Minnesota, USA.2013

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as